Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan H Esensten

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nature Reviews. Rheumatology|October 3, 2009
Regulatory T cells as therapeutic targets in rheumatoid arthritisJonathan H Esensten, David Wofsy, Jeffrey A Bluestone
Annual Review of Pathology|December 14, 2016
Engineering Therapeutic T Cells: From Synthetic Biology to Clinical TrialsJonathan H Esensten, Jeffrey A Bluestone, Wendell A Lim
The Journal of Allergy and Clinical Immunology|October 28, 2018
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontierJonathan H Esensten, Yannick D Muller, Jeffrey A Bluestone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2009
T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system functionJonathan H Esensten, Michael R Lee, Laurie H Glimcher, et al.
Immunity|May 19, 2016
CD28 Costimulation: From Mechanism to TherapyJonathan H Esensten, Ynes A Helou, Gaurav Chopra, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2014
Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labelingArun P Wiita, Gerald W Hsu, Chuanyi M Lu, et al.
Immunological Reviews|April 15, 2011
Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 familyHélène Bour-Jordan, Jonathan H Esensten, Marc Martinez-Llordella, et al.
Cytotherapy|November 15, 2020
Processing laboratory considerations for multi-center cellular therapy clinical trials: a report from the Consortium for Pediatric Cellular ImmunotherapyCatherine Lindgren, Ashley Leinbach, Julie Annis, et al.
Nucleic Acids Research|July 20, 2005
NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress aloneJonathan H Esensten, Alla V Tsytsykova, Cristina Lopez-Rodriguez, et al.
Nature|July 17, 2024
A roadmap for affordable genetic medicinesMelinda Kliegman, Manar Zaghlula, Susan Abrahamson, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nature Reviews. Rheumatology|October 3, 2009
Regulatory T cells as therapeutic targets in rheumatoid arthritisJonathan H Esensten, David Wofsy, Jeffrey A Bluestone
Annual Review of Pathology|December 14, 2016
Engineering Therapeutic T Cells: From Synthetic Biology to Clinical TrialsJonathan H Esensten, Jeffrey A Bluestone, Wendell A Lim
The Journal of Allergy and Clinical Immunology|October 28, 2018
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontierJonathan H Esensten, Yannick D Muller, Jeffrey A Bluestone, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2009
T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system functionJonathan H Esensten, Michael R Lee, Laurie H Glimcher, et al.
Immunity|May 19, 2016
CD28 Costimulation: From Mechanism to TherapyJonathan H Esensten, Ynes A Helou, Gaurav Chopra, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2014
Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labelingArun P Wiita, Gerald W Hsu, Chuanyi M Lu, et al.
Immunological Reviews|April 15, 2011
Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 familyHélène Bour-Jordan, Jonathan H Esensten, Marc Martinez-Llordella, et al.
Cytotherapy|November 15, 2020
Processing laboratory considerations for multi-center cellular therapy clinical trials: a report from the Consortium for Pediatric Cellular ImmunotherapyCatherine Lindgren, Ashley Leinbach, Julie Annis, et al.
Nucleic Acids Research|July 20, 2005
NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress aloneJonathan H Esensten, Alla V Tsytsykova, Cristina Lopez-Rodriguez, et al.
Nature|July 17, 2024
A roadmap for affordable genetic medicinesMelinda Kliegman, Manar Zaghlula, Susan Abrahamson, et al.
Pageof 3